MMS

In just 1 month, MMS will host the much-anticipated PHUSE SDE in South Africa! The SDE is co-chaired by Pieter Cloete, Senior Manager of Statistical Programming at MMS, and will focus on “The Efficiency Journey: Digital Transformation, Automation and Open Source.” This event will provide a valuable opportunity for biometrics experts and professionals to share their experiences and network with peers in the field. See all of the event details and registration link here: https://hubs.li/Q02Gx-W40 #PHUSE #Biometrics #PHUSESDE2024 #SouthAfrica

Clinical trials are becoming more complex, with sites spread further across multiple regions, placing a higher burden on Sponsors for pharmacovigilance regulatory compliance. If you are an early-stage drug development Sponsor or work with one, please attend today's webinar or request a copy of the recording to explore what constitutes a compliant pharmacovigilance program, learn of considerations as the new therapy progresses through key milestones, and understand the proper requirements to make informed decisions. It starts at 11AM EST! Last minute registration is still available here: https://hubs.li/Q02G9frG0 #OneMMS #DrugDevelopment #PV #Pharmacovigilance #DrugSafety #Pharmaceuticals

MMS is happy to share that our article "Unlocking the power of emotional intelligence in medical writers" has been featured in the latest issue of the European Medical Writers Association (EMWA) Journal. 🎉 Within, we discuss: 📝 Characteristics and benefits of medical writers with emotional intelligence 📝 Approaches to enhance emotional intelligence skills 📝 Scales to measure emotional intelligence To read the full EMWA issue, click here: https://hubs.li/Q02F_fzk0 Is emotional intelligence important to you? Share your thoughts in the comments and read our article here: https://hubs.li/Q02F_fPl0 Thank you to Dr. Ananya Bhowmick (PhD), Seema Kaveeshwar, and Susmita Sahu for your leadership in writing this! #MedicalWriting #EmotionalIntelligence #OneMMS

Great news! MMS recently completed the final phase of our annual ISO audit (ISO 9001:2015 and ISO 27001:2022) and we rose to the occasion with absolutely no observations or findings. Thank you to our #OneMMS team who brings a sense of urgency and leadership (SOUL) every day to ensure that quality is the most critical component in the work that we do! MMS remains as one of the few CROs to be ISO certified since inception, standing as a trusted third-party source to verify our credibility among global Sponsors and business partners. Learn more about working with MMS here: https://hubs.li/Q02Fz4Wv0 #ISO9001 #ISO27001 #DrugDevelopment #OneMMS

Happy 4th of July to our US colleagues, clients, and friends from all of us at MMS! As we celebrate Independence Day, we reflect on the values of freedom and innovation, and we celebrate the spirit of collaboration and excellence that defines our team. Together, we continue to push boundaries, drive innovation, and deliver solutions that make a difference. Wishing you all a safe and joyful holiday filled with fun, family, and fireworks! 🌟 #IndependenceDay #OneMMS

New article! To help Sponsor teams in the overwhelming task of identifying and justifying what is and is not company confidential information (CCI), MMS transparency experts just released a new blog post titled, “Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules.” Pre- and post-implementation tips, as well as recommendations for a plan and prepare mindset, are detailed within. Read this: https://hubs.li/Q02FcWKy0 #clinicaltrialtransparency #EUCTR #clinicaltrials

Have you considered combining geospatial and demographic data to aid in site selection for more diverse patient enrollment? It may be worth your time! We've written a detailed article on this topic and how our proprietary Datacise® technology allows users to take their own data and combine it with other data as a background. We detail how multiple layers of data can be displayed simultaneously with near-limitless customization options. This can all be accomplished in a matter of weeks, whereas other tools can take several months to develop! Read our latest article for more on diversifying your patient enrollment: https://hubs.li/Q02DRSyw0 #Diversity #ClinicalTrials #DEI #Pharma #Biotech #ClinicalData #DataScience

Tomorrow, MMS colleagues will attend the Society for Clinical Data Management (SCDM) Single Day Event in Ahmedabad, India! The event explores the intricacies of Risk-Based Data Management (RBDM), with a goal to help attendees embark on a path towards data excellence. The SCDM Single-Day event for 2024, “RBDM Odyssey – From Foundations to Practice” promises to be an enlightening and transformative experience for all attendees. Register now if you haven’t already and we’ll see you there: https://hubs.li/Q02DGRcH0 #SCDM #India #DataManagement #ClinicalData #SCDMIndia

JUST ANNOUNCED: Our global pharmacovigilance experts are coming together to present a new webinar titled, “The Rising Burden of Pharmacovigilance(PV) Requirements in Early Drug Development.” This webinar will cover: 💡 How PV regulations may affect an early-stage drug development program. 💡 Reporting requirements among global health authorities. 💡 Details on individual case safety reports (ICSRs), aggregate reports, and more. 💡 Processes for signal detection and management. Share this event with your network and register here: https://hubs.li/Q02CYtkh0 #OneMMS #DrugDevelopment #PV #Pharmacovigilance #DrugSafety #Pharmaceuticals

📣 New article alert! We just released, “A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry.” Read the full article here 👉 https://hubs.li/Q02CZn2s0 to understand: ✔️ What it is ✔️ What information should be included ✔️ Where it can add value If you have questions about Benefit-Risk Assessments or need support, email us at info@mmsholdings.com, and we’ll connect you with one of our experts. #BenefitRiskAssessment #RiskManagement #REMS #DrugDevelopment #ClinicalResearch